The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma
Open accessAbstract
Limiting dietary carbohydrates inhibits glioma growth in preclinical models. Therefore, the ERGO trial (NCT00575146) examined feasibility of a ketogenic diet in 20 patients with recurrent glioblastoma. Patients were put on a low-carbohydrate, ketogenic diet containing plant oils. Feasibility was the primary endpoint, secondary endpoints included the percentage of patients reaching urinary ketosis, progression-free survival (PFS) and overall survival. The effects of a ketogenic diet alone or in combination with bevacizumab was also explored in an orthotopic U87MG glioblastoma model in nude mice. Three patients (15%) discontinued the diet for poor tolerability. No serious adverse events attributed to the diet were observed. Urine ketosis was achieved at least once in 12 of 13 (92%) evaluable patients. One patient achieved a minor response and two patients had stable disease after 6 weeks. Median PFS of all patients was 5 (range, 3-13) weeks, median survival from enrollment was 32 weeks. The trial allowed to continue the diet beyond progression. Six of 7 (86%) patients treated with bevacizumab and diet experienced an objective response, and median PFS on bevacizumab was 20.1 (range, 12-124) weeks, for a PFS at 6 months of 43%. In the mouse glioma model, ketogenic diet alone had no effect on median survival, but increased that of bevacizumab-treated mice from 52 to 58 days (p<0.05). In conclusion, a ketogenic diet is feasible and safe but probably has no significant clinical activity when used as single agent in recurrent glioma. Further clinical trials are necessary to clarify whether calorie restriction or the combination with other therapeutic modalities, such as radiotherapy or anti-angiogenic treatments, could enhance the efficacy of the ketogenic diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F. M., Bianchi, G., Martin-Montalvo, A., Pistoia, V., Wei, M., Hwang, S., Merlino, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003293 · Cited by 715
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529
de Groot, J. F., Fuller, G., Kumar, A. J., Piao, Y., Eterovic, K., Ji, Y., & Conrad, C. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop027 · Cited by 509
Tumours with PI3K activation are resistant to dietary restriction
Kalaany, N. Y., & Sabatini, D. M. (2009) · Nature · doi:10.1038/nature07782 · Cited by 468
Metabolism of [U‐ 13 C]glucose in human brain tumors in vivo
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341
Nebeling, L. C., Miraldi, F., Shurin, S. B., & Lerner, E. (1995) · Journal of the American College of Nutrition · doi:10.1080/07315724.1995.10718495 · Cited by 311
Zhou, W., Mukherjee, P., Kiebish, M. A., Markis, W. T., Mantis, J. G., & Seyfried, T. N. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-5 · Cited by 299
Abdelwahab, M. G., Fenton, K. E., Preul, M. C., Rho, J. M., Lynch, A., Stafford, P., & Scheck, A. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036197 · Cited by 288
Prediction of Pathology and Survival by FDG PET in Gliomas
Padma, M. V., Said, S., Jacobs, M., Hwang, D. R., Dunigan, K., Satter, M., Christian, B., Ruppert, J., Bernstein, T., Kraus, G., et al. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1025665820001 · Cited by 277
Zuccoli, G., Marcello, N., Pisanello, A., Servadei, F., Vaccaro, S., Mukherjee, P., & Seyfried, T. N. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-33 · Cited by 267
Schmidt, M., Pfetzer, N., Schwab, M., Strauss, I., & Kämmerer, U. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-54 · Cited by 265
Self-citationAccurso, A., Bernstein, R. K., Dahlqvist, A., Draznin, B., Feinman, R. D., Fine, E. J., Gleed, A., Jacobs, D. B., Larson, G., Lustig, R. H., et al. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-9 · Cited by 263
Maurer, G. D., Brucker, D. P., Bähr, O., Harter, P. N., Hattingen, E., Walenta, S., Mueller-Klieser, W., Steinbach, J. P., & Rieger, J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-315 · Cited by 236
Self-citationA Prospective Study of the Modified Atkins Diet for Intractable Epilepsy in Adults
Kossoff, E. H., Rowley, H., Sinha, S. R., & Vining, E. P. G. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01256.x · Cited by 230
Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
Derr, R. L., Ye, X., Islas, M. U., Desideri, S., Saudek, C. D., & Grossman, S. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1098 · Cited by 225
Stafford, P., Abdelwahab, M. G., Kim, D. Y., Preul, M. C., Rho, J. M., & Scheck, A. C. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-74 · Cited by 224
Otto, C., Kaemmerer, U., Illert, B., Muehling, B., Pfetzer, N., Wittig, R., Voelker, H. U., Thiede, A., & Coy, J. F. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-122 · Cited by 213
Self-citationFine, E. J., Segal-Isaacson, C. J., Feinman, R. D., Herszkopf, S., Romano, M. C., Tomuta, N., Bontempo, A. F., Negassa, A., & Sparano, J. A. (2012) · Nutrition · doi:10.1016/j.nut.2012.05.001 · Cited by 200
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/dc06-0997 · Cited by 175
Wanka, C., Steinbach, J. P., & Rieger, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384578 · Cited by 162
Self-citationRoslin, M., Henriksson, R., Bergström, P., Ungerstedt, U., & Bergenheim, A. T. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022106910017 · Cited by 148
DeLay, M., Jahangiri, A., Carbonell, W. S., Hu, Y., Tsao, S. W., Tom, M. W., Paquette, J., Tokuyasu, T. A., & Aghi, M. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2390 · Cited by 122
Steinbach, J., Wolburg, H., Klumpp, A., Probst, H., & Weller, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401252 · Cited by 111
Self-citationHirata, K., Terasaka, S., Shiga, T., Hattori, N., Magota, K., Kobayashi, H., Yamaguchi, S., Houkin, K., Tanaka, S., Kuge, Y., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2037-0 · Cited by 110
Chang, H. T., Olson, L. K., & Schwartz, K. A. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-47 · Cited by 107
Mukherjee, P., Mulrooney, T. J., Marsh, J., Blair, D., Chiles, T. C., & Seyfried, T. N. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-37 · Cited by 103
Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients
Rieger, J., Bähr, O., Müller, K., Franz, K., Steinbach, J. P., & Hattingen, E. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0098-8 · Cited by 100
Self-citationAllen, N. E., Key, T. J., Appleby, P. N., Travis, R. C., Roddam, A., Rinaldi, S., Egevad, L., Rohrmann, S., Linseisen, J., Pischon, T., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1062 · Cited by 100
Mueller-Klieser, W., & Walenta, S. (1993) · The Histochemical Journal · doi:10.1007/bf00157805 · Cited by 93
Self-citationHattingen, E., Jurcoane, A., Bähr, O., Rieger, J., Magerkurth, J., Anti, S., Steinbach, J. P., & Pilatus, U. U. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor132 · Cited by 88
Self-citationMarsh, J., Mukherjee, P., & Seyfried, T. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0213 · Cited by 86
The expression and significance of HIF-1α and GLUT-3 in glioma
Liu, Y., Li, Y., Tian, R., Liu, W., Fei, Z., Long, Q., Wang, X.-A., & Zhang, X. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.083 · Cited by 79
Wanka, C., Brucker, D. P., Bähr, O., Ronellenfitsch, M. W., Weller, M., Steinbach, J. P., & Rieger, J. (2011) · Oncogene · doi:10.1038/onc.2011.530 · Cited by 76
Self-citationFraser, D. A., Thöen, J., Bondhus, S., Haugen, M. A., Reseland, J. E., Djøseland, O., Førre, Ø. T., & Kjeldsen‐Kragh, J. (2000) · PubMed · Cited by 76
Tamura, H., Hatazawa, J., Toyoshima, H., Shimosegawa, E., & Okudera, T. (2002) · Stroke · doi:10.1161/01.str.0000013672.70986.e2 · Cited by 71
Liu, A. G., Most, M. M., Brashear, M. M., Johnson, W. D., Cefalu, W. T., & Greenway, F. L. (2012) · Diabetes Care · doi:10.2337/dc12-0329 · Cited by 59
IGF‐I, IGF binding protein‐3 and breast cancer risk: Comparison of 3 meta‐analyses
Renehan, A. G., Egger, M., Minder, C. E., O’Dwyer, S., Shalet, S. M., & Zwahlen, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20975 · Cited by 36
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
ESPEN practical guideline: Clinical Nutrition in cancer
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Hütterer, E., Isenring, E., Kaasa, S., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.005 · Cited by 1,702
ESPEN practical guideline: Clinical nutrition in surgery
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., Laviano, A., Ljungqvist, O., Lobo, D. N., Martindale, R. G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.031 · Cited by 1,173
Fasting and cancer: molecular mechanisms and clinical application
Nencioni, A., Caffa, I., Cortellino, S., & Longo, V. D. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0061-0 · Cited by 518
Ketogenic diet in the treatment of cancer – Where do we stand?
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.026 · Cited by 464
Metadata
- Authors
- RIEGER, J., BÄHR, O., MAURER, G. D., HATTINGEN, E., FRANZ, K., BRUCKER, D., WALENTA, S., KÄMMERER, U., COY, J. F., WELLER, M., & STEINBACH, J. P.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2014-04-11
- Volume
- 44
- Issue
- 6
- Pages
- 1843-1852
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2143786940
- Cited by
- 287
- References
- 49
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.